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ABSTRACT 
Hypertension is an independent predictor of acute kidney injury (AKI) in non-cardiac surgery patients. There are 
a few published studies which report AKI following non-suprainguinal vascular procedures, but these studies 
have not investigated predictors of AKI, including anti-hypertensive medications and other comorbidities, in the 
hypertensive population alone. We sought to identify independent predictors of post-operative AKI in non-
suprainguinal vascular surgery patients with a pre-operative history of hypertension. We performed univariate 
(chi-squared, or Fisher’s exact testing) and multivariate (binary logistic regression) statistical analysis of pro-
spectively collected data from 243 adult hypertensive patients who underwent non-suprainguinal vascular sur-
gery (lower limb amputation or peripheral artery bypass surgery) at a tertiary hospital between 2008 and 2011 in 
an attempt to identify possible associations between comorbidity, acute pre-operative antihypertensive medica-
tion administration, and post-operative AKI (a post-operative increase in serum creatinine of ≥ 25 % above the 
pre-operative measurement) in these patients. The incidence of post-operative AKI in this study was 5.3 % (95 % 
Confidence Interval: 3.2-8.9 %). Acute pre-operative β-blocker administration was independently associated 
with post-operative AKI in non-suprainguinal vascular surgery patients with a pre-operative history of hyperten-
sion (Odds Ratio: 3.24; 95 % Confidence Interval: 1.03-10.25). The acute pre-operative administration of β-
blockers should be carefully considered in non-suprainguinal vascular surgery patients with a pre-operative his-
tory of hypertension, in lieu of an increased risk of potentially poor post-operative renal outcomes.  
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INTRODUCTION 
Acute kidney injury (AKI) is a signifi-
cant cause of in-hospital morbidity and mor-
tality in hospitalized patients (Borthwick and 
Ferguson, 2010; Chertow et al., 2005). The 
prevalence of AKI following major non-
cardiac surgery varies between 1 % 
(Kheterpal et al., 2009) and 57 % (Macedo et 
al., 2008). Hypertension has been identified 
as an independent predictor of AKI in non-
cardiac surgery patients (Kheterpal et al., 
2009). Amongst vascular surgery patients, 
most studies describe peri-operative renal 
outcomes following suprainguinal proce-
dures, namely abdominal aortic aneurysm 
repair (Thakar, 2013), where an excessively 
high burden of post-operative renal injury is 
often reported. Whilst there are studies 
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which report post-operative AKI following 
non-suprainguinal procedures, such as lower 
limb amputation and peripheral artery bypass 
surgery (Adalbert et al., 2013; Arora et al., 
2013), these studies have failed to investi-
gate predictors of poor post-operative renal 
outcomes, including anti-hypertensive medi-
cations and other comorbidities, in the hy-
pertensive population alone. We sought to 
identify independent predictors of post-
operative AKI in non-suprainguinal vascular 
surgery patients with a pre-operative history 
of hypertension. 
 
MATERIALS AND METHODS 
This study was a sub-analysis of data 
from an ethically approved (University of 
Kwazulu-Natal Biomedical Research Ethics 
Committee approval reference: BF068/07, 
BCA117/010) prospective database of adult 
patients who underwent elective vascular 
surgery at a tertiary hospital located in Dur-
ban, South Africa between 2008 and 2011 
(Moodley et al., 2013).  We considered a pa-
tient to be hypertensive if the patient was 
diagnosed as having hypertension by a phy-
sician, or if the patient was taking any anti-
hypertensive medications (Angiotensin con-
verting enzyme inhibitors - ACEI, β-blockers 
- βB, or calcium channel blockers - CCB). A 
total of 243 patients were included in our 
final analysis, following the exclusion of i) 
patients who did not undergo non-
suprainguinal vascular surgery (lower limb 
amputation or peripheral artery bypass sur-
gery), ii) patients with missing peri-operative 
serum creatinine measurements, iii) patients 
with pre-operative renal dysfunction, as de-
fined in the study by Abelha and colleagues 
(Abelha et al., 2009) as a pre-operative se-
rum creatinine measurement of ≥ 141 
µmol/L in men or ≥ 124 µmol/L in women, 
and iv) patients without a history of hyper-
tension (Figure 1). Data elements collected 
from patient medical records included de-
mographic information (age and gender), 
comorbid conditions (history of diabetes, 
ischaemic heart disease, congestive heart 
failure, stroke), acute pre-operative anti-
hypertensive medication use (ACEI, βB, 
CCB), and peri-operative laboratory test re-
sults (pre- and post-operative serum creati-
nine measurements). The definitions of 
comorbid conditions used in this study were 
adopted from the study of Lee and col-
leagues (Lee et al., 1999). In this study we 
defined post-operative AKI as an increase in 
post-operative serum creatinine ≥ 25 % 
above the pre-operative measurement. We 
had chosen this threshold rather than the cur-
rent Kidney Disease Improving Global Out-
comes group defined serum creatinine in-
crease threshold (Kellum and Lameire, 2013) 
as a large hospital administrative database 
study found a 25 % increase in serum creati-
nine from the baseline measurement was as-
sociated with a 2-fold increased risk of mor-
tality in hospitalized patients (Chertow et al., 
2005). Furthermore, a published meta-
analysis found a 3- to 7-fold increase in risk 
for mortality in hospitalized (surgical and 
non-surgical) patients with serum creatinine 
increases of > 25 % from baseline (Coca et 
al., 2007). Lastly, our definition of AKI is in 
keeping with the definition used in a meta-
analysis of renal outcomes in patients under-
going major surgery (Ho and Morgan, 2009). 
Use of the less liberal Kidney Disease Im-
proving Global Outcomes group definition 
(serum creatinine increase of ≥ 26.5 μmol/l 
from the baseline/pre-operative measure-
ment, or an increase in post-operative serum 
creatinine to ≥ 1.5 times the baseline/pre-
operative measurement) would have there-
fore excluded patients from the analysis with 
a prognostically important serum creatinine 
measurement in the post-operative period.  
Univariate statistical methods used to an-
alyse data included chi-squared and Fisher’s 
Exact testing, where appropriate. For the 
multivariate statistical analysis, a binary lo-
gistic regression model was used to identify 
independent predictors of post-operative 
AKI in non-suprainguinal vascular surgery 
patients with a pre-operative history of hy-
pertension. The clinical variables entered 
into the logistic regression equation were 
purposefully selected, with variables attain-
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ing a significance level of p <0.1 at the uni-
variate analysis level being included in the 
regression analysis. Results for the univariate 
data analysis are presented as frequencies 
and percentages, whilst results for the binary 
logistic regression analyses are presented as 
odds ratios (OR) with 95 % confidence in-
tervals (95 % CI). Any p-value < 0.05 was 
considered to be a statistically significant 
result. All statistical analyses were per-
formed using the Statistical Package for the 
Social Sciences (SPSS) version 21 (SPSS 
Inc., Chicago, IL, USA). 
 
RESULTS 
The process by which patients were se-
lected for inclusion in this study is shown in 
Figure 1. Thirteen of the 243 (5.3 %; 95 % 
CI: 3.2-8.9 %) patients included in our study 
developed post-operative AKI. The baseline 
characteristics of patients included in our 
final analysis are shown in Table 1. A large 
proportion of patients who underwent sur-
gery in the entire cohort were elderly. In ad-
dition, almost two-thirds of the entire cohort 
was male. Diabetes and ischaemic heart dis-
ease were the most prevalent comorbid con-
ditions in the entire cohort. With regard to 
anti-hypertensive medication use, it was 
common for ACEI or βB, and to a lesser ex-
tent CCBs, to have been acutely adminis-
tered prior to a patient’s surgery. 
When stratified by post-operative AKI 
status, no statistically significant univariate 
associations were observed between patient 
demographic factors, comorbidities and post-
operative AKI (Table 1). The point estimates 
for acute pre-operative ACEI and CCB ad-
ministration showed a trend toward post-
operative renal protection in the presence of 
these anti-hypertensive medications. A sta-
tistical trend was also observed for the asso-
ciation between acute pre-operative βB ad-
ministration and post-operative AKI 
(p=0.067, Table 1). This statistical trend sat-
isfied the inclusion criterion for the entry of 
a clinical variable into the logistic regression 
analysis in our study (p<0.1 at the univariate 
 
 
 
 
 
Figure 1: Derivation of the final study cohort 
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analysis level). When entered into a logistic 
regression equation, acute pre-operative βB 
administration was found to be independent-
ly associated with post-operative AKI in 
non-suprainguinal vascular surgery patients 
who had a pre-operative history of hyperten-
sion (OR: 3.24; 95 % CI: 1.03-10.25). 
 
DISCUSSION 
Five of every 100 hypertensive patients 
undergoing non-suprainguinal vascular sur-
gery in this study suffered post-operative 
AKI. The incidence of post-operative AKI in 
our study was lower than that reported for 
two other studies of non-suprainguinal vas-
cular surgery, which reported the incidence 
of post-operative AKI to be 12 % and 12.7 % 
(Adalbert et al., 2013; Arora et al., 2013).  
Pre-operative renal dysfunction is an im-
portant determinant of post-operative renal 
outcomes. Although a lower incidence of 
post-operative AKI in the combined hyper-
tensive-normotensive populations described 
in the aforementioned studies would be ex-
pected, our study population was different in 
that we had investigated renal outcomes in 
patients with normal pre-operative renal 
function, and excluded patients with pre-
operative renal dysfunction from our final 
analysis. However, patients with pre-
operative renal dysfunction were included in 
the two other studies of AKI in non-
suprainguinal vascular surgery patients 
(Adalbert et al., 2013; Arora et al., 2013), 
thereby explaining the higher incidence of 
post-operative AKI reported in these studies. 
In contrast to other studies of non-cardiac 
and vascular surgery patients (Adalbert et al., 
2013; Arora et al., 2013; Kheterpal et al., 
2009), we did not observe associations be-
tween any of the patient demographic char-
acteristics or comorbidities and post-
operative AKI in our study. It is likely that 
our study was not adequately powered to de-
termine the impact of these variables on 
post-operative AKI. Similarly, it appears our 
study was not adequately powered to inves-
tigate the effects of acute pre-operative 
ACEI and CCB administration on post-
operative renal outcomes. It is important to 
note however, that ACEI and CCB were as-
sociated with a trend toward renal protection 
in the post-operative period, as opposed to 
acute pre-operative βB use, which was asso-
ciated with post-operative renal injury. 
 
 
Table 1: Clinical characteristics of patients with and without post-operative AKI expressed as a fre-
quency (percentage) 
Clinical  
characteristic 
All patients 
(n=243) 
Patients with 
post-operative 
AKI (n=13) 
Patients without 
post-operative 
AKI (n=230) 
p-value 
Male gender 160 (65.8) 8 (61.5) 152 (66.1) 0.768 
Age > 65 years old 107 (44.0) 8 (61.5) 99 (43.0) 0.191 
Ischaemic heart  
disease 
110 (45.3) 7 (53.8) 103 (44.8) 0.523 
Diabetes 166 (68.3) 7 (53.8) 159 (69.1) 0.357 
Congestive heart 
failure 
15 (6.2) 2 (15.4) 13 (5.7) 0.187 
Stroke 34 (14.0) 2 (15.4) 32 (13.9) 1.000 
Acute pre-operative 
CCB administration 
47 (19.3) 2 (15.4) 45 (19.6) 1.000 
Acute pre-operative 
ACEI administration 
143 (58.8) 6 (42.2) 137 (59.6) 0.339 
Acute pre-operative 
βB administration 
84 (34.6) 8 (61.5) 76 (33.0) 0.067 
AKI: Acute kidney injury, CCB: Calcium channel blockers, ACEI: Angiotensin converting enzyme inhibitors, βB: β-blockers; 
p < 0.05 was considered a statistically significant result. 
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We found acute pre-operative βB admin-
istration to be associated with a 3-fold in-
creased risk of developing post-operative 
AKI in this study. In another study, we had 
reported that acute pre-operative βB admin-
istration was associated with a higher risk of 
peri-operative troponin leak and peri-
operative major adverse cardiovascular 
events in vascular surgery patients with a 
pre-operative history of hypertension 
(Moodley and Biccard, 2015). In that study 
we postulated that vascular surgery patients 
with a pre-operative history of poorly con-
trolled hypertension might be pre-disposed 
towards peri-operative hypotension. The pe-
ri-operative hypotension might have been 
further exacerbated by acute pre-operative 
βB administration, resulting in a higher inci-
dence of peri-operative cardiac morbidity 
and mortality in patients who received acute 
pre-operative βB versus patients who did not 
receive acute pre-operative βB in that study 
(Moodley and Biccard, 2015). Similarly, it is 
therefore possible that acute pre-operative 
βB administration exacerbates global peri-
operative hypotension in patients with poorly 
controlled pre-operative hypertension, result-
ing in ischaemic injury of the kidney. The 
potentially aggravating effects of acute pre-
operative βB administration on global peri-
operative hypotension observed in this study 
are further supported by the findings of the 
POISE study (Devereaux et al., 2008), 
wherein acutely administered pre-operative 
metoprolol was found to be independently 
associated with a higher incidence of peri-
operative hypotension and peri-operative 
stroke following non-cardiac surgery. The 
findings of our research have potential im-
plications for peri-operative medication 
management in vascular surgery patients, 
particularly those with a pre-operative histo-
ry of hypertension. Our study was not with-
out limitations. It is likely that our study was 
underpowered to investigate the impact of 
patient demographic variables, other comor-
bidities, and the acute pre-operative use of 
ACEI and CCB on the incidence of post-
operative AKI. A larger patient cohort would 
be required to adequately investigate this.  
In conclusion, acute pre-operative β-
blockade was associated with a higher risk of 
post-operative AKI in non-suprainguinal 
vascular surgery patients with a pre-
operative history of hypertension. Although 
this research requires validation in a larger 
cohort, our findings suggest that the acute 
pre-operative administration of βB should be 
carefully considered in non-suprainguinal 
vascular surgery patients who have a pre-
operative history of hypertension. 
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